Closing Bell Recap: Terns Pharmaceuticals Inc (TERN) Ends at $34.11, Reflecting a -3.86% Downturn

Abby Carey

Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.

Terns Pharmaceuticals Inc (NASDAQ: TERN) closed the day trading at $34.11 down -3.86% from the previous closing price of $35.48. In other words, the price has decreased by -$3.86 from its previous closing price. On the day, 2.5 million shares were traded. TERN stock price reached its highest trading level at $35.8225 during the session, while it also had its lowest trading level at $33.43.

Ratios:

For a better understanding of TERN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 19.52 and its Current Ratio is at 19.52. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

On October 15, 2025, Truist started tracking the stock assigning a Buy rating and target price of $20.Truist initiated its Buy rating on October 15, 2025, with a $20 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 05 ’26 when Burroughs Amy L. sold 71,339 shares for $38.10 per share. The transaction valued at 2,718,230 led to the insider holds 138,976 shares of the business.

Kuriakose Emil sold 1,155 shares of TERN for $44,552 on Jan 02 ’26. The Chief Medical Officer now owns 50,365 shares after completing the transaction at $38.57 per share. On Nov 04 ’25, another insider, Quigley Jill M., who serves as the Director of the company, sold 24,520 shares for $18.00 each. As a result, the insider received 441,360 and left with 0 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TERN now has a Market Capitalization of 3710052096 and an Enterprise Value of 2778015232.

Stock Price History:

The Beta on a monthly basis for TERN is -0.29, which has changed by 6.763676 over the last 52 weeks, in comparison to a change of 0.19226205 over the same period for the S&P500. Over the past 52 weeks, TERN has reached a high of $48.26, while it has fallen to a 52-week low of $1.87. The 50-Day Moving Average of the stock is 8.50%, while the 200-Day Moving Average is calculated to be 189.68%.

Shares Statistics:

Over the past 3-months, TERN traded about 4.00M shares per day on average, while over the past 10 days, TERN traded about 2114600 shares per day. A total of 106.33M shares are outstanding, with a floating share count of 89.84M. Insiders hold about 15.40% of the company’s shares, while institutions hold 69.24% stake in the company. Shares short for TERN as of 1767139200 were 15452240 with a Short Ratio of 3.87, compared to 1764288000 on 8781897. Therefore, it implies a Short% of Shares Outstanding of 15452240 and a Short% of Float of 14.21.

Earnings Estimates

The company has 9.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is -$0.3, with high estimates of -$0.25 and low estimates of -$0.34.

Analysts are recommending an EPS of between -$1.01 and -$1.2 for the fiscal current year, implying an average EPS of -$1.09. EPS for the following year is -$1.21, with 9.0 analysts recommending between -$0.76 and -$1.54.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.